Navigation Links
King's to develop unique sunscreen with Aethic
Date:9/11/2012

King's College London has entered into an agreement with skincare company Aethic to develop the first sunscreen based on MAA's (mycosporine-like amino acids), produced by coral.

It was last year that a team led by Dr Paul Long at King's discovered how the naturally-occurring MAA's were produced. Algae living within coral make a compound that is transported to the coral, which then modifies it into a sunscreen for the benefit of both the coral and the algae. Not only does this protect them both from UV damage, but fish that feed on the coral also benefit from this sunscreen protection.

The next phase of development is for the researchers to work with Professor Antony Young and colleagues at the St John's Institute of Dermatology at King's, to test the efficacy of the compounds using human skin models.

Aethic's Sve sunscreen was selected as the best 'host' product for the compound because of its existing broad-spectrum UVA/UVB and photo-stability characteristics and scientifically proven ecocompatibility credentials.

Dr Paul Long, Reader in Pharmacognosy at King's Institute of Pharmaceutical Science, said: "While MAA's have a number of other potential applications, human sunscreen is certainly a good place to begin proving the compound's features. If our further studies confirm the results we are expecting, we hope that we will be able to develop a sunscreen with the broadest spectrum of protection. Aethic has the best product and philosophy with which to proceed this exciting project."

Allard Marx, CEO of Aethic, added: "With the recent launch of Sve we believe that we are already leading the industry. Together with King's we would like to raise our product benefits to an even higher level using MAA's. We are very excited about the potential."


'/>"/>
Contact: Emma Reynolds
emma.reynolds@kcl.ac.uk
44-207-848-4334
King's College London
Source:Eurekalert

Page: 1

Related medicine news :

1. Tumor cells inner workings predict cancer progression
2. LWW announces 57% growth in 2011 impact factor rankings
3. Former Vikings and NFL Greats Tackle Sleep Apnea at Upcoming Minneapolis Event
4. Strategy developed to improve delivery of medicines to the brain
5. New collaboration to develop treatments for liver disease
6. Kids Develop Sense of Humor by Age 1, Study Finds
7. Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
8. New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
9. A model for development
10. NIH scientists map first steps in flu antibody development
11. Adelaide joins with Italy to develop super spaghetti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology: